Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Nortriptyline hydrochloride
Drug ID BADD_D01589
Description Nortriptyline hydrochloride, the active metabolite of [amitriptyline], is a tricyclic antidepressant (TCA).[L11878] It is used in the treatment of major depression and is also used off-label for chronic pain and other conditions.[L11881]
Indications and Usage Nortriptyline is indicated for the relief of the symptoms of major depressive disorder (MDD).[L11878] Some off-label uses for this drug include treatment of chronic pain, myofascial pain, neuralgia, and irritable bowel syndrome.[A191083,L11878]
Marketing Status approved
ATC Code N06AA10
DrugBank ID DB00540
KEGG ID D00816
MeSH ID D009661
PubChem ID 441358
TTD Drug ID D04WFD
NDC Product Code 51927-0128; 50090-0507; 50090-1323; 50268-604; 51672-4004; 60760-811; 0406-9913; 70518-3485; 70771-1612; 70771-1613; 50090-0537; 55700-501; 60760-508; 61919-590; 63187-396; 63187-798; 51927-2175; 0121-0678; 51672-4002; 68788-7216; 68788-8158; 70518-0708; 70518-3543; 70710-1155; 71205-254; 71335-0155; 60687-265; 70518-0702; 71205-770; 71335-2199; 49452-4858; 54154-007; 64330-018; 50268-603; 60687-281; 60687-293; 63187-715; 63187-759; 0406-9912; 70518-0741; 70518-1522; 70710-1154; 70771-1615; 72189-177; 62991-2905; 71554-011; 43063-897; 51672-4001; 51862-946; 0406-9910; 0406-9911; 68788-9830; 70710-1153; 80425-0299; 17337-0534; 66577-025; 0093-0810; 0093-0812; 51655-507; 70710-1156; 70771-1614; 71335-0083; 0093-0813; 43063-722; 61919-353; 71335-0426; 71335-1552; 71335-1726; 71335-1743; 50268-605; 51862-945; 51862-947; 60760-401; 63629-3204; 68071-3211; 68788-8202; 71335-1773; 46438-0049; 63187-809; 70934-954; 71335-0065; 0093-0811; 51672-4003; 51862-016; 51862-948; 55700-668; 58118-4002
UNII 00FN6IH15D
Synonyms Nortriptyline | Desitriptyline | Desmethylamitriptylin | Allegron | Apo-Nortriptyline | Apo Nortriptyline | Aventyl | Gen-Nortriptyline | Gen Nortriptyline | Paxtibi | Nortrilen | Nortriptyline Hydrochloride | Hydrochloride, Nortriptyline | Novo-Nortriptyline | Novo Nortriptyline | Nu-Nortriptyline | Nu Nortriptyline | Pamelor | PMS-Nortriptyline | PMS Nortriptyline | ratio-Nortriptyline | ratio Nortriptyline | Norfenazin
Chemical Information
Molecular Formula C19H22ClN
CAS Registry Number 894-71-3
SMILES CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Galactorrhoea21.05.02.002; 05.03.04.002--Not Available
Generalised oedema08.01.07.004; 14.05.06.007--
Gynaecomastia21.05.04.003; 05.05.02.003--
Hallucination19.10.04.003--
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypertension24.08.02.001--
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hypomania19.16.02.001--Not Available
Hypotension24.06.03.002--
Ileus paralytic07.02.05.001--Not Available
Insomnia17.15.03.002; 19.02.01.002--
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Jaundice cholestatic09.01.01.005--Not Available
Libido decreased21.03.02.005; 19.08.03.001--
Libido increased19.08.03.002; 21.03.02.007--
Malaise08.01.01.003--
Micturition disorder20.02.02.005--Not Available
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Myocardial infarction24.04.04.009; 02.02.02.007--
Nausea07.01.07.001--
Neuropathy peripheral17.09.03.003--Not Available
Nightmare19.02.03.003--Not Available
Nocturia20.02.03.001--Not Available
Palpitations02.11.04.012--
Panic reaction19.06.04.003--Not Available
Paraesthesia17.02.06.005; 23.03.03.094--
Parotid gland enlargement07.06.03.001--Not Available
Petechiae23.06.01.003; 01.01.03.002; 24.07.06.004--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages